Literature DB >> 6215342

The induction of lymphocytes with the capacity to render macrophages cytotoxic in an allogeneic murine system.

R A De Weger, E Pels, W Den Otter.   

Abstract

Sensitized spleen and peripheral lymph node lymphocytes were tested after different types of immunization with allogeneic tumour cells for their capacity to induce macrophage cytotoxicity in vitro. The macrophages were rendered cytotoxic either by direct contact with lymphocytes and tumour cells (activation of macrophages) or by a factor (macrophage arming factor, MAF), released by the sensitized lymphocytes incubated with tumour cells (arming of macrophages). Both types of reactions are T-cell dependent. Macrophage activation is a more sensitive way to detect lymphocytes with the capacity to render macrophages cytotoxic than arming of macrophages. The route of immunization subcutaneously (s.c.) or intraperitoneally (i.p.) with allogeneic cells did not influence the induction of lymphocytes with the capacity to render macrophages cytotoxic. However, the tumour cells had to be intact as disrupted cells (suspended in Freund's complete adjuvant, FCA) did not induce macrophages activating lymphocytes. The adjuvant dimethyl dioctadecyl ammonium bromide (DDA) did not increase the lymphocyte response. Intact allogeneic tumour cells were needed in vitro when used for secondary antigenic stimulation. This secondary stimulation was independent of antigen presentation by macrophages. This suggests that also in vivo the primary response is independent of macrophage antigen presentation. Delayed-type hypersensitivity and antibody responses against the allogeneic tumour cells were comparable after s.c. and i.p. immunization and after immunization with FCA and DDA.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6215342      PMCID: PMC1555532     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  15 in total

1.  Cellular immunity to murine sarcoma virus-induced tumors as measured by macrophage migration inhibition assays.

Authors:  S Landolfo; R B Herberman; H T Holden
Journal:  J Natl Cancer Inst       Date:  1977-12       Impact factor: 13.506

2.  Influence of cyclophosphamide on the delayed hypersensitivity of the mouse.

Authors:  J A Kerckhaert; G J Van den Berg; J M Willers
Journal:  Ann Immunol (Paris)       Date:  1974 Mar-Apr

3.  Differentiation of immunologically specific cytotoxic macrophages into two types on the basis of radiosensitivity.

Authors:  W Den Otter; R Evans; P Alexander
Journal:  Transplantation       Date:  1974-11       Impact factor: 4.939

4.  Mechanism of immunologically specific killing of tumour cells by macrophages.

Authors:  R Evans; P Alexander
Journal:  Nature       Date:  1972-03-24       Impact factor: 49.962

5.  Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity.

Authors:  R Evans; P Alexander
Journal:  Immunology       Date:  1972-10       Impact factor: 7.397

6.  Delayed hypersensitivity in the mouse.

Authors:  A J Crowle
Journal:  Adv Immunol       Date:  1975       Impact factor: 3.543

7.  Dimethyl diotadecyl ammonium bromide as adjuvant for delayed hypersensitivity in mice.

Authors:  H Snippe; M Belder; J M Willers
Journal:  Immunology       Date:  1977-12       Impact factor: 7.397

8.  Effects of dimethyldioctadecylammonium bromide on phagocytosis and digestion of Listeria monocytogenes by mouse peritoneal macrophages.

Authors:  F M Hofhuis; C Van der Meer; M C Kersten; V P Rutten; J M Willers
Journal:  Immunology       Date:  1981-07       Impact factor: 7.397

9.  Demonstration in tissue culture of lymphocyte-mediated immunity to tuberculosis.

Authors:  R J Patterson; G P Youmans
Journal:  Infect Immun       Date:  1970-06       Impact factor: 3.441

10.  Natural cytotoxic macrophages in the peritoneal cavity of mice.

Authors:  E Pels; W Den Otter
Journal:  Br J Cancer       Date:  1979-12       Impact factor: 7.640

View more
  10 in total

1.  Initial immunochemical characterization of specific macrophage-arming factor.

Authors:  R A De Weger; R J Vandebriel; H Slager; D Mans; H Van Loveren; B Wilbrink; H F Dullens; W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  The role of host lymphocytes and host macrophages in antitumor reactions after injection of sensitized lymphocytes and tumor target cells into naive mice.

Authors:  H F Dullens; W Vuist; M Van der Maas; W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

Review 3.  Macrophages and antitumor reactions.

Authors:  W Den Otter; H F Dullens; R A De Weger
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

4.  Production of specific macrophage-arming factor precedes cytotoxic T lymphocyte activity in vivo during tumor rejection.

Authors:  H F Dullens; R A De Weger; M Van der Maas; P J Den Besten; R J Vandebriel; W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

5.  Eradication of tumor cells after injection into immunized hosts compared with the eradication of tumor cells after transfer of immune peritoneal exudates into tumor-bearing recipients.

Authors:  W Den Otter; J W De Groot; H F Dullens
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

6.  Macrophage infiltration in tumors and tumor-surrounding tissue: influence of serotonin and sensitized lymphocytes.

Authors:  G Los; R A De Weger; D T Van den Berg; R Sakkers; W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

7.  A survey of some formal models in tumor immunology.

Authors:  H F Dullens; M W Van der Tol; R A De Weger; W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

8.  The absence of delayed-type hypersensitivity reactivity in a syngeneic murine tumour system.

Authors:  G Los; R A De Weger; R M Moberts; H Van Loveren; R J Sakkers; W Den Otter
Journal:  Immunology       Date:  1987-09       Impact factor: 7.397

9.  Immune reactivity in SL2 lymphoma-bearing mice compared with SL2-immunized mice.

Authors:  R A De Weger; B Wilbrink; R M Moberts; D Mans; R Oskam; W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

10.  Specific tumoricidal activity of cytotoxic macrophages and cytotoxic lymphocytes.

Authors:  H F Dullens; S Schakenraad; A Oostdijk; W Vuist; M Van der Maas; W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.